Effects of pre-existing left ventricular hypertrophy on ventricular dysfunction and remodeling following myocardial infarction in rats

被引:5
作者
Nass, O
Yang, XP
Liu, YH
Carretero, OA
Khaja, F
Goldstein, S
Sabbah, HN
机构
[1] Henry Ford Heart & Vasc Inst, Div Cardiovasc Med, Detroit, MI USA
[2] Henry Ford Heart & Vasc Inst, Div Hypertens & Vasc Res, Detroit, MI USA
关键词
D O I
10.1016/S1053-2498(02)00432-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Myocardial hypertrophy is a characteristic component of left ventricular (LV) remodeling that may, at least initially, have a beneficial effect on LV function following myocardial infarction (MI). In the present, study, we examine the effects of pre-existing left ventricular hypertrophy (LVH) on LV function and chamber enlargement following MI in inbred Lewis rats. Methods: The one-kidney, one-clip model (1K1C) of hypertension was used to produce LVH. Four weeks after 1K1C, rats were randomized to left anterior descending coronary artery ligation (LVH + MI group, n = 8) or sham ligation (LVH group, n = 11). Another group of rats underwent sham 1K1C. Four weeks later, they were randomized to coronary ligation (MI group, n = 12) or sham ligation (Sham group, n = 12). LV end-diastolic pressure (EDP, mm Hg), end-diastolic volume (EDV, ml), end-systolic volume (ESV, ml) and ejection fraction (EF) (determined by angiography) were measured in all groups 2 months after MI. Results: LV EDP was 20 +/- 2 mm Hg in the LVH + MI group compared with 9 +/- 1 mm Hg in the MI group (p < 0.05). LV EDV and ESV were significantly greater with LVH + MI than with MI alone (EDV 0.90 +/- 0.03 vs 0.75 +/- 0.02 ml; ESV 0.68 0.02. vs 0.50 +/- 0.03 ml; p < 0.05). Pre-existing LVH resulted in a greater reduction in EF following MI (25 +/- 2% for LVH + MI vs 34 +/- 2% for MI alone; p < 0.05). Conclusions: Pre-existing LVH is an important determinant of progressive LV dysfunction and remodeling following MI in Lewis inbred rats.
引用
收藏
页码:1113 / 1119
页数:7
相关论文
共 51 条
[1]   BODY-FLUID VOLUME AND ANGIOTENSIN-II IN MAINTENANCE OF ONE-KIDNEY, ONE CLIP HYPERTENSION [J].
AKAHOSHI, M ;
CARRETERO, OA .
HYPERTENSION, 1989, 14 (03) :269-273
[2]   ISCHEMIC CARDIOMYOPATHY - PATHOPHYSIOLOGIC MECHANISMS [J].
ANVERSA, P ;
SONNENBLICK, EH .
PROGRESS IN CARDIOVASCULAR DISEASES, 1990, 33 (01) :49-70
[3]  
ANVERSA P, 1978, LAB INVEST, V38, P597
[4]   MECHANISMS OF MYOCYTE AND CAPILLARY GROWTH IN THE INFARCTED HEART [J].
ANVERSA, P ;
CAPASSO, JM ;
SONNENBLICK, EH ;
OLIVETTI, G .
EUROPEAN HEART JOURNAL, 1990, 11 :123-132
[5]   LEFT-VENTRICULAR FAILURE INDUCED BY MYOCARDIAL-INFARCTION .1. MYOCYTE HYPERTROPHY [J].
ANVERSA, P ;
LOUD, AV ;
LEVICKY, V ;
GUIDERI, G .
AMERICAN JOURNAL OF PHYSIOLOGY, 1985, 248 (06) :H876-H882
[6]  
BREISCH EA, 1984, LAB INVEST, V51, P333
[7]   REGULATION OF THE STRUCTURAL REMODELING OF THE MYOCARDIUM - FROM HYPERTROPHY TO HEART-FAILURE [J].
BRILLA, CG ;
MAISCH, B .
EUROPEAN HEART JOURNAL, 1994, 15 :45-52
[8]   HYPERTENSION OF RENAL ORIGIN - EVIDENCE FOR 2 DIFFERENT MECHANISMS [J].
BRUNNER, HR ;
KIRSHMAN, JD ;
SEALEY, JE ;
LARAGH, JH .
SCIENCE, 1971, 174 (4016) :1344-+
[9]   THE EFFECTS OF PRESSURE-INDUCED CARDIAC-HYPERTROPHY ON THE FUNCTIONAL-CAPACITY OF THE CORONARY CIRCULATION [J].
DELLSPERGER, KC ;
MARCUS, ML .
AMERICAN JOURNAL OF HYPERTENSION, 1988, 1 (02) :200-207
[10]   ENHANCED HYPOTHALAMIC NORADRENALINE BIOSYNTHESIS IN GOLDBLATT-I RENOVASCULAR HYPERTENSION [J].
DEQUATTRO, V ;
EIDE, I ;
MYERS, MR ;
EIDE, K ;
KOLLOCH, R ;
WHIGHAM, H .
CLINICAL SCIENCE AND MOLECULAR MEDICINE, 1978, 55 :S109-S111